Pfizer Inc. (PFE)
| Previous Close | 49.49 |
| Open | 49.64 |
| Bid | 0.00 x 1300 |
| Ask | 0.00 x 2900 |
| Day's Range | 49.13 - 49.73 |
| 52 Week Range | 41.45 - 61.71 |
| Volume | |
| Avg. Volume | 19,901,860 |
| Market Cap | 277.55B |
| Beta (5Y Monthly) | 0.64 |
| PE Ratio (TTM) | 9.47 |
| EPS (TTM) | 5.22 |
| Earnings Date | Feb 06, 2023 - Feb 10, 2023 |
| Forward Dividend & Yield | 1.60 (3.23%) |
| Ex-Dividend Date | Nov 03, 2022 |
| 1y Target Est | 54.78 |
- Motley Fool
3 Reasons Pfizer Stock Will Crush the Broader Market in 2023
Pfizer (NYSE: PFE) is a 173-year-old company with a huge portfolio of products. This year, Pfizer has dropped about 16%, in line with the S&P 500. In fact, there are three reasons Pfizer stock could crush the broader market in 2023.
- Zacks
Novavax (NVAX) Stock Nosedives 88% This Year: Here's Why
Novavax (NVAX) drops to record lows as the delayed product launch of its COVID-19 vaccine made it lose market share. Management slashes revenue guidance by more than half.
- Business Wire
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
NEW YORK, November 28, 2022--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with Angela Hwang, Chief Commercial Officer, President, Global Biopharmaceuticals Business; Kevin Sullivan, Global Specialty Care & U.S. President; and Navin Katyal, U.S. Commercial and Global Business Lead for mRNA Portfolio, at the Evercore ISI HealthCONx Conference on Thursday, December 1, 2022 at 4:20 p.m. EST.
